However, our finding of 8.9% FGFR1 amplification in ESCC is almost identical to a recent FISH study on Asian ESCC, reporting 8.6% amplification using the same threshold (ratio ≥ 2.0) for amplification [26]. This evidence concerns the gene FGFR1 and esophageal squamous cell carcinoma.